These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10847559)

  • 1. L-glutamate, L-arginine and L-citrulline levels in cerebrospinal fluid of Parkinson's disease, multiple system atrophy, and Alzheimer's disease patients.
    Kuiper MA; Teerlink T; Visser JJ; Bergmans PL; Scheltens P; Wolters EC
    J Neural Transm (Vienna); 2000; 107(2):183-9. PubMed ID: 10847559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease is not associated with altered concentrations of the nitric oxide synthase inhibitor asymmetric dimethylarginine in cerebrospinal fluid.
    Mulder C; Wahlund LO; Blomberg M; de Jong S; van Kamp GJ; Scheltens P; Teerlink T
    J Neural Transm (Vienna); 2002 Sep; 109(9):1203-8. PubMed ID: 12203047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal cerebrospinal fluid glutathione concentrations in Parkinson's disease, Alzheimer's disease and multiple system atrophy.
    Konings CH; Kuiper MA; Teerlink T; Mulder C; Scheltens P; Wolters EC
    J Neurol Sci; 1999 Oct; 168(2):112-5. PubMed ID: 10526192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
    Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
    Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased cerebrospinal fluid nitrate levels in Parkinson's disease, Alzheimer's disease and multiple system atrophy patients.
    Kuiper MA; Visser JJ; Bergmans PL; Scheltens P; Wolters EC
    J Neurol Sci; 1994 Jan; 121(1):46-9. PubMed ID: 8133311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-synuclein in the cerebrospinal fluid differentiates synucleinopathies (Parkinson Disease, dementia with Lewy bodies, multiple system atrophy) from Alzheimer disease.
    Tateno F; Sakakibara R; Kawai T; Kishi M; Murano T
    Alzheimer Dis Assoc Disord; 2012; 26(3):213-6. PubMed ID: 22037599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arginine, citrulline and nitrate concentrations in the cerebrospinal fluid from patients with acute hydrocephalus.
    Pérez-Neri I; Castro E; Montes S; Boll MC; Barges-Coll J; Soto-Hernández JL; Ríos C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 851(1-2):250-6. PubMed ID: 17110176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid Abeta42 is reduced in multiple system atrophy but normal in Parkinson's disease and progressive supranuclear palsy.
    Holmberg B; Johnels B; Blennow K; Rosengren L
    Mov Disord; 2003 Feb; 18(2):186-90. PubMed ID: 12539213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in the cerebrospinal fluid during aging and in patients with Alzheimer's disease.
    Abe T; Tohgi H; Murata T; Isobe C; Sato C
    Neurosci Lett; 2001 Oct; 312(3):177-9. PubMed ID: 11602339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid levels of neurofilament light chain in multiple system atrophy relative to Parkinson's disease: a meta-analysis.
    Hu X; Yang Y; Gong D
    Neurol Sci; 2017 Mar; 38(3):407-414. PubMed ID: 27896490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of metabotropic glutamate receptor-mediated nitric oxide production in vivo.
    Bhardwaj A; Northington FJ; Martin LJ; Hanley DF; Traystman RJ; Koehler RC
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):153-60. PubMed ID: 9040494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-arginine and nitric oxide in CNS function and neurodegenerative diseases.
    Virarkar M; Alappat L; Bradford PG; Awad AB
    Crit Rev Food Sci Nutr; 2013; 53(11):1157-67. PubMed ID: 24007420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complementary distribution of NADPH-diaphorase and l-arginine in the snail nervous system.
    Xie M; Hermann A; Kerschbaum HH
    Cell Tissue Res; 2002 Mar; 307(3):393-400. PubMed ID: 11904776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased levels of neuronal thread protein in cerebrospinal fluid of patients with Alzheimer's disease.
    de la Monte SM; Volicer L; Hauser SL; Wands JR
    Ann Neurol; 1992 Dec; 32(6):733-42. PubMed ID: 1471863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders.
    Hall S; Öhrfelt A; Constantinescu R; Andreasson U; Surova Y; Bostrom F; Nilsson C; Håkan W; Decraemer H; Någga K; Minthon L; Londos E; Vanmechelen E; Holmberg B; Zetterberg H; Blennow K; Hansson O
    Arch Neurol; 2012 Nov; 69(11):1445-52. PubMed ID: 22925882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement 3 and factor h in human cerebrospinal fluid in Parkinson's disease, Alzheimer's disease, and multiple-system atrophy.
    Wang Y; Hancock AM; Bradner J; Chung KA; Quinn JF; Peskind ER; Galasko D; Jankovic J; Zabetian CP; Kim HM; Leverenz JB; Montine TJ; Ginghina C; Edwards KL; Snapinn KW; Goldstein DS; Shi M; Zhang J
    Am J Pathol; 2011 Apr; 178(4):1509-16. PubMed ID: 21435440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson's Disease and Multiple System Atrophy.
    Marques TM; Kuiperij HB; Bruinsma IB; van Rumund A; Aerts MB; Esselink RAJ; Bloem BR; Verbeek MM
    Mol Neurobiol; 2017 Dec; 54(10):7736-7745. PubMed ID: 27844283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-β1 in the cerebrospinal fluid of patients with distinct neurodegenerative diseases.
    Masuda T; Itoh J; Koide T; Tomidokoro Y; Takei Y; Ishii K; Tamaoka A
    J Clin Neurosci; 2017 Jan; 35():47-49. PubMed ID: 27756506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid levels of non-neurotransmitter amino acids in patients with Alzheimer's disease.
    Molina JA; Jiménez-Jiménez FJ; Vargas C; Gómez P; de Bustos F; Ortí-Pareja M; Tallón-Barranco A; Benito-León J; Arenas J; Enríquez-de-Salamanca R
    J Neural Transm (Vienna); 1998; 105(2-3):279-86. PubMed ID: 9660106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease.
    Holmberg B; Rosengren L; Karlsson JE; Johnels B
    Mov Disord; 1998 Jan; 13(1):70-7. PubMed ID: 9452329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.